Lates News

Moderna plunged nearly 20% in intraday trading, while Merck & Co. also weakened, falling nearly 3%. Well-known blogger TOGI disclosed that he has positioned an all-in put option on Moderna, believing that the market has overly high expectations for the mRNA cancer vaccine jointly developed by the two companies.